Even before botulinum toxin (Botox Cosmetic) received FDA approval in April for use in cosmetic procedures, the demand for the treatment had made Botox the fifth most common nonsurgical cosmetic procedure in the country.
New Dermatology Social Comparison Scale Demonstrates Acceptable Psychometrics for Clinical and Research Applications
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
A Novel Approach to Distinguishing Scabies From Atopic Dermatitis
ReV Up Your Vitiligo Treatment Strategies
In Interim Analysis, Mogamulizumab Demonstrates Improvements In Mycosis Fungoides, Sézary Syndrome
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know